![](/img/cover-not-exists.png)
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)
P. Heffeter, M.A. Jakupec, W. Körner, P. Chiba, C. Pirker, R. Dornetshuber, L. Elbling, H. Sutterlüty, M. Micksche, B.K. Keppler, W. BergerVolume:
73
Year:
2007
Language:
english
Pages:
14
DOI:
10.1016/j.bcp.2007.03.002
File:
PDF, 1.70 MB
english, 2007